$337.81
1.00% day before yesterday
NYSE, Oct 31, 09:04 pm CET
ISIN
US03073E1055
Symbol
COR

Cencora Stock price

$337.81
+25.28 8.09% 1M
+45.14 15.42% 6M
+113.13 50.35% YTD
+109.73 48.11% 1Y
+180.59 114.86% 3Y
+238.87 241.43% 5Y
+239.98 245.30% 10Y
+318.74 1,671.65% 20Y
NYSE, Closing price Fri, Oct 31 2025
-3.40 1.00%

Key metrics

Basic
Market capitalization
$65.5b
Enterprise Value
$71.5b
Net debt
$6.0b
Cash
$2.2b
Shares outstanding
193.9m
Valuation (TTM | estimate)
P/E
34.8 | 21.0
P/S
0.2 | 0.2
EV/Sales
0.2 | 0.2
EV/FCF
62.6
P/B
33.1
Dividends
DPS
$2.20
Yield 1Y | 5Y
0.7% | 1.1%
Growth 1Y | 5Y
7.8% | 5.8%
Payout 1Y | 3Y
27.1% | 24.2%
Increased
20 Years
Financials (TTM | estimate)
Revenue
$316.7b | $324.2b
EBITDA
$4.5b | $4.8b
EBIT
$3.5b | $4.3b
Net Income
$1.9b | $3.1b
Free Cash Flow
$1.1b
Growth (TTM | estimate)
Revenue
11.6% | 10.3%
EBITDA
13.4% | 15.0%
EBIT
19.2% | 40.1%
Net Income
2.2% | 106.8%
Free Cash Flow
-70.2%
Margin (TTM | estimate)
Gross
3.4%
EBITDA
1.4% | 1.5%
EBIT
1.1%
Net
0.6% | 1.0%
Free Cash Flow
0.4%
Financial Health
Equity Ratio
1.0%
Return on Equity
233.6%
ROCE
17.3%
ROIC
-
Debt/Equity
4.2
More
EPS
$9.7
FCF per Share
$5.9
Short interest
4.2%
Employees
44k
Rev per Employee
$6.7m
Show more

Is Cencora a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Cencora Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Cencora forecast:

16x Buy
73%
6x Hold
27%

Analyst Opinions

22 Analysts have issued a Cencora forecast:

Buy
73%
Hold
27%

Financial data from Cencora

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
316,654 316,654
12% 12%
100%
- Direct Costs 305,884 305,884
12% 12%
97%
10,771 10,771
13% 13%
3%
- Selling and Administrative Expenses 6,235 6,235
12% 12%
2%
- Research and Development Expense - -
-
-
4,535 4,535
13% 13%
1%
- Depreciation and Amortization 1,069 1,069
2% 2%
0%
EBIT (Operating Income) EBIT 3,466 3,466
19% 19%
1%
Net Profit 1,897 1,897
2% 2%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Cencora directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Cencora Stock News

Positive
Seeking Alpha
about 17 hours ago
This is my latest article where I provide predictions of upcoming dividend increases from companies with long-term dividend growth histories. The pattern of modest dividend increases continues, with only three of 19 companies announcing double-digit percentage boosts in October. November brings a larger chance of 10%+ increases from several companies, including industrials Roper Technologies an...
Neutral
Business Wire
17 days ago
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part of this expansion, IntrinsiQ is now also offering oncology biomarker data, enabling physicians to transition from a generalized treatment approach to precision ...
Negative
Barrons
19 days ago
Those looking to buy stocks right now should look for the ones that aren't correlated to the artificial intelligence trade.
More Cencora News

Company Profile

AmerisourceBergen Corp. engages provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes a comprehensive offering of brand-name, specialty brand-name & generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies & equipment, outsourced compounded sterile preparations, and related services to a wide variety of healthcare providers, including acute care hospitals and health systems, independent & chain retail pharmacies, mail order pharmacies, medical clinics, long-term care & alternate site pharmacies, and other customers. The Other segment focuses on global commercialization services and animal health and includes ABCS, World Courier, and MWI. The company was founded in 1947 and is headquartered in Chesterbrook, PA.

Head office United States
CEO Robert Mauch
Employees 44,000
Founded 1947
Website www.cencora.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today